Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OMDA
HOLDOmada Health, Inc. · Healthcare · United States · $1.2B · Avg Vol: $25M/d
COMPANY DESCRIPTION
Omada Health, Inc. delivers virtual care programs focused on preventing and managing chronic conditions such as diabetes and hypertension through a digital platform. The company distinguishes itself by combining personalized human coaching with evidence-based digital interventions, forming strategic partnerships with health plans and employers to reach a broad patient base.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 89.2M | 122.8M | 169.8M | 260.2M | 42.9% | 283.3M | 328.0M | 392.2M | 22.8% |
| EPS | -1.52 | -1.41 | -0.85 | -0.35 | — | -0.23 | — | — | — |
| Shares | 55.7M | 55.7M | 55.7M | 58.4M | +4.8% | 59.4M | — | — | — |
| Debt | 30.8M | 30.6M | 30.2M | 0 | -1.0% | — | — | — | — |
| Equity | 155.6M | 98.9M | -384.4M | 229.7M | 13.9% | — | — | — | — |
| Op CF | -69.0M | -49.7M | -34.2M | 18.3M | — | 22.5M | — | — | — |
| Inv CF | -2.7M | -2.9M | -3.9M | -5.8M | — | — | — | — | — |
| Fin CF | 16.3M | 0.2M | -1.2M | 133.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OMDA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OMDA | Omada Health, Inc.(you) | $1.2B | 62 | HOLD |
| CERT | Certara, Inc. | $1.2B | 55 | HOLD |
| TALK | Talkspace, Inc. | $873M | 64 | HOLD |
| OMCL | Omnicell, Inc. | $1.9B | 66 | BUY |
| GDRX | GoodRx Holdings, Inc. | $1.0B | 77 | BUY |
| MDRX | Veradigm Inc. | $517M | 65 | HOLD |
| TDOC | Teladoc Health, Inc. | $1.6B | 77 | BUY |
| WEAV | Weave Communications, Inc. | $491M | 60 | HOLD |
| DOCS | Doximity, Inc. | $3.7B | 62 | HOLD |
| PRVA | Privia Health Group, Inc. | $3.2B | 57 | HOLD |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%